News

This MS awareness month, Dr. Carolina Garcia, a neurologist at Saint Luke's Comprehensive Multiple Sclerosis Center, discusses diagnosing and treating this inflammatory and presumed autoimmune condition.

Growing research shows why popular GLP-1 weight loss medications might be beneficial for people with multiple sclerosis, but the jury’s still out.

Dr. Adnan Chhatriwalla, interventional cardiologist at Saint Luke’s Mid America Heart Institute, talks about symptoms of heart valve disease, treatment, and keys to long-term heart health.

Empower yourself by learning all you can about therapies for multiple sclerosis.

Cardiovascular Business spoke with Dr. Timothy Bateman about his views on SPECT advances and its longevity in the coming years.

Dr. Timothy Bateman spoke with Cardiovascular Business about his group's findings and what it is like to work with flurpiridaz.

FOX4 talked to Dr. Karin Olds about Guillain-Barre Syndrome and recovery.

A recent study out of Harvard School of Public Health found a strong relationship between those who had mononucleosis, or the “kissing disease,” and multiple sclerosis later in life.

An expert with Saint Luke’s Comprehensive Multiple Sclerosis Center discusses early detection and exciting new advances in treatment.

Saint Luke’s dedication to research means more patients have alternatives to care—like Hilda Lankard and Agnes Lickteig.